Delabeling patients from chemotherapy and biologics allergy: Implementing drug provocation testing.

Autor: Vázquez-Revuelta P; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Allergy Service, Internal Medicine Department, Bellvitge University Hospital, Barcelona, Spain. Electronic address: pauvazrev@gmail.com., Martí-Garrido J; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Allergy Service, Internal Medicine Department, Bellvitge University Hospital, Barcelona, Spain., Molina-Mata K; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Medical Oncology Service, Catalan Institute of Oncology, Barcelona, Spain., Lleonart-Bellfill R; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Allergy Service, Internal Medicine Department, Bellvitge University Hospital, Barcelona, Spain., Rey-Salido M; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Pharmacy Service, Catalan Institute of Oncology, Barcelona, Spain., Madrigal-Burgaleta R; Drug Desensitisation Centre, Catalan Institute of Oncology, Barcelona, Spain; Allergy & Severe Asthma Service, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Jazyk: angličtina
Zdroj: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Apr; Vol. 9 (4), pp. 1742-1745.e1. Date of Electronic Publication: 2020 Nov 24.
DOI: 10.1016/j.jaip.2020.11.021
Databáze: MEDLINE